Restructuring completed with focus on private label, leading to one-off costs but improved adjusted EBIT. Record order backlog, new production lines, and international expansion set the stage for targeted 30% annual growth and a return to profitability.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.